How much revenue does Makers Laboratories make?

Makers Laboratories reported 1.20 billion INR in revenue for fiscal year 2025, up 15.4% from 1.04 billion INR in fiscal year 2024. In Q3 2026 revenue was 356.68 million INR.

What companies are similar to Makers Laboratories?

Listed companies of a similar size in the same industry (drug manufacturing contractors) include Par Drugs and Chemicals Limited (PAR.NS), Krebs Biochemicals & Industries Limited (KREBSBIO.NS), Alpa Laboratories Limited (ALPA.NS), Panchsheel Organics Limited (PANCHSHEEL.BO).

Makers Laboratories Limited (MAKERSL.BO) Stock

About Makers Laboratories Limited

Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing. The company offers general health therapeutic products, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-...

At a glance

Makers Laboratories reported revenue of 1.20 billion INR for fiscal year 2025, up 15.4% from fiscal year 2024, and net income of 74.91 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 356.68 million INR, up 28.8% from a year before.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.